Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · IEX Real-Time Price · USD
6.11
+0.04 (0.66%)
At close: Jul 19, 2024, 4:00 PM
6.05
-0.06 (-0.98%)
Pre-market: Jul 22, 2024, 7:23 AM EDT

Vanda Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2004
Revenue
177.6192.64254.38268.68248.17227.19
Upgrade
Revenue Growth (YoY)
-30.81%-24.27%-5.32%8.27%9.23%17.64%
Upgrade
Cost of Revenue
13.4614.824.2825.6323.3624.49
Upgrade
Gross Profit
164.14177.84230.1243.05224.8202.7
Upgrade
Selling, General & Admin
106.86112.88136.49124.05140.51129.74
Upgrade
Research & Development
78.7476.8285.7775.3655.5848.65
Upgrade
Other Operating Expenses
3.732.091.521.481.481.51
Upgrade
Operating Expenses
189.33191.8223.77200.89197.57179.89
Upgrade
Operating Income
-25.19-13.956.3342.1727.2422.81
Upgrade
Other Expense / Income
-21.34-20.29-4.97-0.2-4.42-6.22
Upgrade
Pretax Income
-3.856.3411.342.3631.6629.03
Upgrade
Income Tax
1.043.835.039.218.32-86.53
Upgrade
Net Income
-4.892.516.2833.1523.34115.55
Upgrade
Net Income Growth
--60.02%-81.07%42.06%-79.80%358.40%
Upgrade
Shares Outstanding (Basic)
585756565453
Upgrade
Shares Outstanding (Diluted)
585857575555
Upgrade
Shares Change
0.63%1.01%0.11%3.14%0.63%3.40%
Upgrade
EPS (Basic)
-0.090.040.110.600.432.17
Upgrade
EPS (Diluted)
-0.090.040.110.580.422.11
Upgrade
EPS Growth
--63.64%-81.03%38.10%-80.09%339.58%
Upgrade
Free Cash Flow
-11.7712.4231.3163.6649.9844.93
Upgrade
Free Cash Flow Per Share
-0.200.220.551.150.920.85
Upgrade
Gross Margin
92.42%92.32%90.45%90.46%90.59%89.22%
Upgrade
Operating Margin
-14.18%-7.24%2.49%15.69%10.98%10.04%
Upgrade
Profit Margin
-2.75%1.30%2.47%12.34%9.40%50.86%
Upgrade
Free Cash Flow Margin
-6.63%6.45%12.31%23.69%20.14%19.78%
Upgrade
Effective Tax Rate
-60.42%44.47%21.74%26.28%-298.07%
Upgrade
EBITDA
0.719.3514.0345.2134.5231.92
Upgrade
EBITDA Margin
0.40%4.85%5.52%16.82%13.91%14.05%
Upgrade
Depreciation & Amortization
4.563.012.732.842.862.89
Upgrade
EBIT
-3.856.3411.342.3631.6629.03
Upgrade
EBIT Margin
-2.17%3.29%4.44%15.77%12.76%12.78%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).